XML 31 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Changes in Shareholder Equity
Share Capital
Psyence Group Inc
shares
Share Capital
NCAC Sponsor
USD ($)
shares
Share Capital
Third party advisors
USD ($)
shares
Share Capital
USD ($)
shares
Reserve
USD ($)
Deficit
USD ($)
Psyence Group Inc
shares
NCAC Sponsor
USD ($)
Third party advisors
USD ($)
USD ($)
shares
CAD ($)
shares
Opening balance as at beginning at Mar. 31, 2022       $ 4,537,055 $ 255,188 $ (3,093,543)       $ 1,698,700  
Psyence Group contribution       1,397,086           1,397,086  
Net loss for the period           (3,206,403)       (3,206,403)  
Other comprehensive income (loss)         (89,828)         (89,828)  
Balance at end at Mar. 31, 2023       5,934,141 165,360 (6,299,946)       $ (200,445) $ (200,445)
Balance at end (in shares) at Mar. 31, 2023 | shares                   0 0
Issuance of shares, reverse takeover transaction   $ 37,336,416           $ 37,336,416      
Issuance of shares, reverse takeover transaction (in shares) | shares 5,000,000 7,794,659         5,000,000     150,000 150,000
Issuance of shares for debt settlement       $ 718,500           $ 718,500  
Issuance of shares for debt settlement (in shares) | shares       150,000              
Issuance of shares     $ 2,136,340           $ 2,136,340    
Issuance of shares (in shares) | shares     446,000                
Net loss for the period           (51,159,048)       (51,159,048)  
Balance at end at Mar. 31, 2024       $ 46,125,397 $ 361,057 $ (57,458,994)       $ (10,972,540)  
Balance at end (in shares) at Mar. 31, 2024 | shares       13,390,659           13,390,659 13,390,659